Home > NRC Library > ADAMS Public Documents

631905 Amendment No. 5 (Corrected Copy) POINT Biopharma USA Inc. to License No. 13-35593-01

Accession Number: ML22258A113

Date Released: Wednesday, September 21, 2022

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML22258A110 - 631905 Identification-Request for Amendment Correction for POINT Biopharma USA Inc. to License No. 13-35593-01 (2 page(s), 9/13/2022)
• ML22258A107 - 631905 Cover Letter (Corrected Copy) for POINT Biopharma USA Inc. to License No. 13-35593-01 (2 page(s), 9/15/2022)